Saturday 17 October 2026
Export BIMI’s income statement to Excel — free account
BIMI Holdings Inc.
BIMI Healthcare Pharmaceutical Retailers
0.00
0.00
NaN
Follow BIMI
| Older periods | Dec '22 | Mar '23 | Jun '23 | Sep '23 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(270.56%) | (184.46%) | (94.42%) | (117.43%) | |
Piotroski F-Score |
5 | 5 | 6 | 7 | |
| (62.01%) | (54.15%) | (33.05%) | (35.12%) | ||
ROIC |
(290.38%) | (98.67%) | (49.39%) | (62.31%) | |
Return on Tangible Assets |
(1,626.59%) | (487.96%) | (153.16%) | (203.21%) | |
Average Days of Receivables |
98.98 | 116.06 | 154.82 | 119.12 | |
Free Cash Flow per Share |
(3.85) | (0.52) | (0.94) | (0.58) | |
Free Cash Flow |
(10.26) | (2.01) | (4.32) | (3.71) | |
Capital Expenditures |
— | — | — | (0.81) | |
| Other line items | |||||
Cash ROIC |
(128.60%) | (17.58%) | (29.43%) | (32.85%) | |
Accounts Receivable Turnover |
2.61 | 2.01 | 2.38 | 2.19 | |
Accounts Payable Turnover |
1.00 | 0.91 | 1.10 | 0.96 | |
Inventory Turnover |
2.00 | 1.70 | 1.83 | 1.81 | |
Average Days of Payables |
508.54 | 508.96 | 414.17 | 530.59 | |
Days of Inventory on Hand |
282.76 | 341.59 | 280.01 | 343.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
100.61% | 85.19% | 58.74% | 71.12% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(90.01) | (22.12) | (17.70) | (22.75) | |
Operating CF/Net income |
0.46 | 0.10 | 0.34 | 0.24 | |
Depreciation/Fixed assets |
2.05 | 1.49 | 1.15 | 0.72 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.68) | |
Revenue per Share |
4.44 | 3.21 | 3.27 | 1.96 | |
Operating CF per Share |
(3.85) | (0.52) | (0.94) | (0.45) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.13) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.06 |
Columns are period end dates